Imperforated hymen with hematocolpos with CA 125 and CA 19-9 increased
DOI:
https://doi.org/10.47456/rbps.v23isupl_1.36582Keywords:
Hematocolpia, Menstrual disorders, Urinary retention, BiomarkersAbstract
Introduction: Imperforate hymen (HI) is the most common obstructive anomaly of the female genital tract. When present in adolescents, it generates a progressive accumulation of blood in the vaginal cavity, and with it, symptoms such as: abdominal and pelvic pain, often cyclical, low back pain and urinary retention, which can progress to anuria and hydronephrosis. Case report: A 13-year-old girl was referred to our service with a 12-day history of progressive abdominal pain, an abdominal-pelvic mass and acute urinary retention. She had elevated CA125 and CA19.9 and had an initial ultrasound diagnosis of an ovarian mass. She did not have dysuria, vomiting or fever and reported menarche for 2 months, in small amounts, without new episodes of menstruation. The diagnosis of HI was made by the presence of hematocolpos on a new ultrasound, confirmed by physical examination. Subsequently, she underwent hymenotomy with emptying of the hematocolpus. The patient evolved with total improvement of pain and spontaneous urination. CA 125 and CA 19.9 are markers widely used for screening for ovarian and pancreatic cancer, among others, but they also increase in benign conditions. Conclusion: Most publications related to HI are descriptions of clinical presentations, complications and treatment. This case is one of the few in the literature that demonstrates HI associated with increased levels of CA 19.9 and CA 125. The mechanism that leads to this increase may be inflammation of the epithelial tissues (peritoneal, vaginal and uterine), generated by obstruction of the desquamation of tissue. Late discovery of an imperforate hymen can cause pain, infection, hydronephrosis, endometriosis, and infertility.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors and reviewers must disclose any financial, professional, or personal conflicts of interest that could influence the results or interpretations of the work. This information will be treated confidentially and disclosed only as necessary to ensure transparency and impartiality in the publication process.
Copyright
RBPS adheres to the CC-BY-NC 4.0 license, meaning authors retain copyright of their work submitted to the journal.
- Originality Declaration: Authors must declare that their submission is original, has not been previously published, and is not under review elsewhere.
- Publication Rights: Upon submission, authors grant RBPS the exclusive right of first publication, subject to peer review.
- Additional Agreements: Authors may enter into non-exclusive agreements for the distribution of the RBPS-published version (e.g., in institutional repositories or as book chapters), provided the original authorship and publication by RBPS are acknowledged.
Authors are encouraged to share their work online (e.g., institutional repositories or personal websites) after initial publication in RBPS, with appropriate citation of authorship and original publication.
Under the CC-BY-NC 4.0 license, readers have the rights to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material.
These rights cannot be revoked, provided the following terms are met:
- Attribution: Proper credit must be given, a link to the license provided, and any changes clearly indicated.
- Non-Commercial: The material cannot be used for commercial purposes.
- No Additional Restrictions: No legal or technological measures may be applied to restrict others from doing anything the license permits.